• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug Information
 

FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug Information

on

  • 1,601 views

Draft FDA guidance focusing on how drug firms should respond to unsolicited requests for information about drugs and medical devices.

Draft FDA guidance focusing on how drug firms should respond to unsolicited requests for information about drugs and medical devices.

Statistics

Views

Total Views
1,601
Views on SlideShare
1,601
Embed Views
0

Actions

Likes
1
Downloads
18
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug Information FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug Information Document Transcript